Treanda and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Treanda (bendamustine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Rituxan, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Treanda. It is created by eHealthMe based on reports of 4,378 people who have side effects when taking Treanda from the FDA, and is updated regularly.

What is Treanda?

Treanda has active ingredients of bendamustine hydrochloride. It is often used in non-hodgkin's lymphoma. eHealthMe is studying from 4,411 Treanda users. Check the latest studies of Treanda.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,754 drugs and 2,913 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

On Jul, 13, 2026

4,378 people reported to have side effects when taking Treanda.
Among them, 43 people (0.98%) have Hypersensitivity.

Among these 43 people:

How long have people been on Treanda when they have Hypersensitivity? *

What is the gender of people who have Hypersensitivity when taking Treanda? *

female: 40 %
male: 60 %

What is the age of people who have Hypersensitivity when taking Treanda? *

What are other drugs people take besides Treanda? *

What are other side effects people have besides Hypersensitivity? *

Rashes (redness): 11 people, 25.58%
Chills (felling of cold): 9 people, 20.93%
Fever: 9 people, 20.93%
Nausea (feeling of having an urge to vomit): 7 people, 16.28%
Hypotension (abnormally low blood pressure): 6 people, 13.95%
Acute Kidney Failure: 5 people, 11.63%
Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 11.63%
Diarrhea: 5 people, 11.63%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 9.30%
Thrombocytopenia (decrease of platelets in blood): 4 people, 9.30%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 14 people, 32.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.98%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 4.65%
Lymphoma (cancer that begins in immune system cells): 2 people, 4.65%
Glioma (a type of tumour that starts in the brain or spine): 2 people, 4.65%
Galactorrhea (secretion of breast milk in men): 2 people, 4.65%
Anaplastic Astrocytoma (tumour of the glial (supportive) tissue of the brain): 2 people, 4.65%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 2.33%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 2.33%
Pain: 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Treanda and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Treanda:

Treanda (4,411 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

Browse all side effects of Treanda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,754 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,913 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bendamustine hydrochloride (the active ingredients of Treanda) and Treanda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.